Vinge advises SEB Kort Bank AB in connection with its acquisition of Lufthansa AirPlus Servicekarten GmbH

June 21, 2023 M&A

SEB Kort Bank AB ("SEB Kort"), a wholly-owned subsidiary within the SEB Group, has entered into an agreement with Lufthansa Group to acquire all shares in Lufthansa AirPlus Servicekarten GmbH ("AirPlus").

Together, SEB Kort and AirPlus will become a leading European player in the corporate payments sector. For a cash consideration of EUR 450 million, the transaction will provide SEB Kort with additional scale, a strong position for further growth in Europe, and a modern IT platform. In addition, the transaction is expected to result in synergies and also complement SEB's broader ambitions in the corporate business in the DACH region (Germany, Austria, and Switzerland) and northern Europe.

In connection with the transaction, Vinge has acted as local counsel for SEB Kort and assisted with Swedish corporate and regulatory matters.

The transaction is, inter alia, subject to approvals from governmental authorities.

Vinge's team consisted of Daniel Rosvall and Viktor Lennartsson (M&A) as well as Caroline Krassén (Financial Services).


Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023